塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/12/25 | 6,842 | 6,863 | 6,824 | 6,833 | -10 | -0.1% | 430,000 |
2019/12/24 | 6,783 | 6,857 | 6,783 | 6,843 | +55 | +0.8% | 718,100 |
2019/12/23 | 6,801 | 6,834 | 6,730 | 6,788 | -113 | -1.6% | 1,611,500 |
2019/12/20 | 6,847 | 6,937 | 6,826 | 6,901 | +99 | +1.5% | 1,866,800 |
2019/12/19 | 6,725 | 6,825 | 6,710 | 6,802 | +112 | +1.7% | 1,436,600 |
2019/12/18 | 6,607 | 6,700 | 6,599 | 6,690 | +140 | +2.1% | 1,685,100 |
2019/12/17 | 6,487 | 6,571 | 6,449 | 6,550 | +123 | +1.9% | 1,147,700 |
2019/12/16 | 6,450 | 6,497 | 6,425 | 6,427 | -91 | -1.4% | 1,103,800 |
2019/12/13 | 6,480 | 6,547 | 6,432 | 6,518 | +112 | +1.7% | 1,803,300 |
2019/12/12 | 6,468 | 6,468 | 6,394 | 6,406 | -117 | -1.8% | 824,200 |
2019/12/11 | 6,500 | 6,532 | 6,472 | 6,523 | +42 | +0.6% | 1,031,900 |
2019/12/10 | 6,428 | 6,482 | 6,408 | 6,481 | +77 | +1.2% | 1,017,900 |
2019/12/09 | 6,382 | 6,411 | 6,358 | 6,404 | +52 | +0.8% | 985,200 |
2019/12/06 | 6,424 | 6,441 | 6,336 | 6,352 | -114 | -1.8% | 1,287,500 |
2019/12/05 | 6,425 | 6,483 | 6,400 | 6,466 | +66 | +1% | 823,600 |
2019/12/04 | 6,366 | 6,440 | 6,360 | 6,400 | -66 | -1% | 818,000 |
2019/12/03 | 6,433 | 6,513 | 6,431 | 6,466 | -51 | -0.8% | 933,100 |
2019/12/02 | 6,475 | 6,524 | 6,442 | 6,517 | +79 | +1.2% | 682,900 |
2019/11/29 | 6,510 | 6,524 | 6,429 | 6,438 | -61 | -0.9% | 713,300 |
2019/11/28 | 6,451 | 6,501 | 6,422 | 6,499 | +24 | +0.4% | 698,100 |
2019/11/27 | 6,488 | 6,547 | 6,464 | 6,475 | +30 | +0.5% | 1,280,900 |
2019/11/26 | 6,530 | 6,532 | 6,422 | 6,445 | -96 | -1.5% | 1,498,700 |
2019/11/25 | 6,471 | 6,554 | 6,435 | 6,541 | +143 | +2.2% | 1,198,100 |
2019/11/22 | 6,356 | 6,428 | 6,352 | 6,398 | +46 | +0.7% | 985,300 |
2019/11/21 | 6,435 | 6,464 | 6,313 | 6,352 | -83 | -1.3% | 1,238,100 |
2019/11/20 | 6,370 | 6,435 | 6,353 | 6,435 | +72 | +1.1% | 869,400 |
2019/11/19 | 6,415 | 6,420 | 6,344 | 6,363 | -6 | -0.1% | 668,400 |
2019/11/18 | 6,349 | 6,371 | 6,312 | 6,369 | +80 | +1.3% | 750,600 |
2019/11/15 | 6,205 | 6,312 | 6,205 | 6,289 | +90 | +1.5% | 938,100 |
2019/11/14 | 6,237 | 6,253 | 6,162 | 6,199 | -60 | -1% | 835,300 |
2019/11/13 | 6,324 | 6,347 | 6,253 | 6,259 | -65 | -1% | 876,300 |
2019/11/12 | 6,307 | 6,351 | 6,274 | 6,324 | +10 | +0.2% | 959,200 |
2019/11/11 | 6,336 | 6,367 | 6,300 | 6,314 | -22 | -0.3% | 718,500 |
2019/11/08 | 6,415 | 6,420 | 6,313 | 6,336 | -24 | -0.4% | 1,186,600 |
2019/11/07 | 6,389 | 6,447 | 6,343 | 6,360 | -57 | -0.9% | 988,600 |
2019/11/06 | 6,382 | 6,445 | 6,363 | 6,417 | +67 | +1.1% | 1,190,200 |
2019/11/05 | 6,393 | 6,393 | 6,255 | 6,350 | +8 | +0.1% | 1,456,500 |
2019/11/01 | 6,455 | 6,488 | 6,327 | 6,342 | -176 | -2.7% | 1,164,400 |
2019/10/31 | 6,273 | 6,541 | 6,251 | 6,518 | +281 | +4.5% | 2,086,000 |
2019/10/30 | 6,329 | 6,372 | 6,226 | 6,237 | -49 | -0.8% | 1,669,300 |
2019/10/29 | 6,300 | 6,323 | 6,225 | 6,286 | -11 | -0.2% | 1,066,300 |
2019/10/28 | 6,279 | 6,307 | 6,246 | 6,297 | +57 | +0.9% | 1,095,200 |
2019/10/25 | 6,152 | 6,242 | 6,142 | 6,240 | +114 | +1.9% | 1,120,400 |
2019/10/24 | 6,137 | 6,158 | 6,107 | 6,126 | +44 | +0.7% | 843,100 |
2019/10/23 | 6,059 | 6,084 | 5,985 | 6,082 | +79 | +1.3% | 1,285,400 |
2019/10/21 | 6,078 | 6,078 | 5,992 | 6,003 | -75 | -1.2% | 855,000 |
2019/10/18 | 6,084 | 6,102 | 6,028 | 6,078 | -6 | -0.1% | 1,147,400 |
2019/10/17 | 5,984 | 6,117 | 5,982 | 6,084 | +106 | +1.8% | 1,294,100 |
2019/10/16 | 5,931 | 6,080 | 5,906 | 5,978 | +111 | +1.9% | 1,835,900 |
2019/10/15 | 5,926 | 5,934 | 5,851 | 5,867 | -17 | -0.3% | 1,440,900 |
1201~
1250
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム